Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group
- Author
- DAPONTE, Antonio1 ; ASCIERTO, Paolo A2 ; GRAVINA, Adriano1 ; MELUCCI, Maria Teresa3 ; PALMIERI, Giuseppe4 ; COMELLA, Pasquale1 ; CELLERINO, Riccardo5 ; DELENA, Mario6 ; MARINI, Giovanni7 ; COMELLA, Giuseppe1
[1] Division of Medical Oncology A, National Tumor Institute, Naples, Italy
[2] Division of Clinical Immunology, National Tumor Institute, Naples, Italy
[3] Division of Surgical Oncology, National Tumor Institute, Naples, Italy
[4] Division of Cancer Genetics, Institute of Molecular Genetics, C.N.R., Alghero (SS), Italy
[5] Division of Clinical Oncology, University of Ancona, Ancona, Italy
[6] Division of Medical Oncology, Oncologic Institute of Bari, Bari, Italy
[7] Division of Medical Oncology, Spedali Civili, Brescia, Italy - Source
Cancer. 2000, Vol 89, Num 12, pp 2630-2636 ; ref : 32 ref
- CODEN
- CANCAR
- ISSN
- 0008-543X
- Scientific domain
- Medical oncology
- Publisher
- Wiley-Liss, New York, NY
- Publication country
- United States
- Document type
- Article
- Language
- English
- Keyword (fr)
- Agent alkylant Anticancéreux Association médicamenteuse Chimiothérapie Dacarbazine Essai clinique phase II Fotémustine Homme Immunothérapie Interféron alpha Mélanome Nitrosourées Peau Pronostic Stade avancé Traitement associé Voie intraveineuse Italie Cytokine Peau pathologie Tumeur maligne Europe
- Keyword (en)
- Alkylating agent Antineoplastic agent Drug combination Chemotherapy Dacarbazine Phase II trial Fotemustine Human Immunotherapy Alpha interferon Melanoma Nitrosoureas Skin Prognosis Advanced stage Combined treatment Intravenous administration Italy Cytokine Skin disease Malignant tumor Europe
- Keyword (es)
- Agente alquilante Anticanceroso Asociación medicamentosa Quimioterapia Dacarbazina Ensayo clínico fase II Fotemustina Hombre Inmunoterapia Interferón alfa Melanoma Nitrosoureas Piel Pronóstico Estadio avanzado Tratamiento asociado Vía intravenosa Italia Citoquina Piel patología Tumor maligno Europa
- Classification
- Pascal
- 002 Biological and medical sciences / 002B Medical sciences / 002B02 Pharmacology. Drug treatments / 002B02R Antineoplastic agents / 002B02R04 Combined treatments (chemotherapy of immunotherapy associated with an other treatment)
- Discipline
- Pharmacological treatments
- Origin
- Inist-CNRS
- Database
- PASCAL
- INIST identifier
- 908101
Sauf mention contraire ci-dessus, le contenu de cette notice bibliographique peut être utilisé dans le cadre d’une licence CC BY 4.0 Inist-CNRS / Unless otherwise stated above, the content of this bibliographic record may be used under a CC BY 4.0 licence by Inist-CNRS / A menos que se haya señalado antes, el contenido de este registro bibliográfico puede ser utilizado al amparo de una licencia CC BY 4.0 Inist-CNRS
Install on your browser
"O:13:\"PanistOpenUrl\":36:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000idc\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2630\";s:8:\"\u0000*\u0000epage\";s:4:\"2636\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DAPONTE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Antonio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"ASCIERTO, Paolo A\";i:1;s:16:\"GRAVINA, Adriano\";i:2;s:21:\"MELUCCI, Maria Teresa\";i:3;s:18:\"PALMIERI, Giuseppe\";i:4;s:17:\"COMELLA, Pasquale\";i:5;s:19:\"CELLERINO, Riccardo\";i:6;s:13:\"DELENA, Mario\";i:7;s:16:\"MARINI, Giovanni\";i:8;s:17:\"COMELLA, Giuseppe\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Panist access
"O:12:\"IstexOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2630\";s:8:\"\u0000*\u0000epage\";s:4:\"2636\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DAPONTE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Antonio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"ASCIERTO, Paolo A\";i:1;s:16:\"GRAVINA, Adriano\";i:2;s:21:\"MELUCCI, Maria Teresa\";i:3;s:18:\"PALMIERI, Giuseppe\";i:4;s:17:\"COMELLA, Pasquale\";i:5;s:19:\"CELLERINO, Riccardo\";i:6;s:13:\"DELENA, Mario\";i:7;s:16:\"MARINI, Giovanni\";i:8;s:17:\"COMELLA, Giuseppe\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Istex access
"O:16:\"EuropePMCOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2630\";s:8:\"\u0000*\u0000epage\";s:4:\"2636\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DAPONTE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Antonio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"ASCIERTO, Paolo A\";i:1;s:16:\"GRAVINA, Adriano\";i:2;s:21:\"MELUCCI, Maria Teresa\";i:3;s:18:\"PALMIERI, Giuseppe\";i:4;s:17:\"COMELLA, Pasquale\";i:5;s:19:\"CELLERINO, Riccardo\";i:6;s:13:\"DELENA, Mario\";i:7;s:16:\"MARINI, Giovanni\";i:8;s:17:\"COMELLA, Giuseppe\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Europe PubMed Central access
"O:11:\"BaseOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2630\";s:8:\"\u0000*\u0000epage\";s:4:\"2636\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DAPONTE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Antonio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"ASCIERTO, Paolo A\";i:1;s:16:\"GRAVINA, Adriano\";i:2;s:21:\"MELUCCI, Maria Teresa\";i:3;s:18:\"PALMIERI, Giuseppe\";i:4;s:17:\"COMELLA, Pasquale\";i:5;s:19:\"CELLERINO, Riccardo\";i:6;s:13:\"DELENA, Mario\";i:7;s:16:\"MARINI, Giovanni\";i:8;s:17:\"COMELLA, Giuseppe\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
Base Search access
"O:12:\"ArXivOpenUrl\":35:{s:10:\"\u0000*\u0000openUrl\";N;s:6:\"\u0000*\u0000fmt\";s:7:\"journal\";s:6:\"\u0000*\u0000doi\";s:0:\"\";s:6:\"\u0000*\u0000pii\";s:0:\"\";s:7:\"\u0000*\u0000pmid\";s:0:\"\";s:9:\"\u0000*\u0000atitle\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:9:\"\u0000*\u0000jtitle\";s:6:\"Cancer\";s:9:\"\u0000*\u0000stitle\";s:6:\"Cancer\";s:7:\"\u0000*\u0000date\";s:4:\"2000\";s:9:\"\u0000*\u0000volume\";s:2:\"89\";s:8:\"\u0000*\u0000issue\";s:2:\"12\";s:8:\"\u0000*\u0000spage\";s:4:\"2630\";s:8:\"\u0000*\u0000epage\";s:4:\"2636\";s:8:\"\u0000*\u0000pages\";s:0:\"\";s:7:\"\u0000*\u0000issn\";s:9:\"0008-543X\";s:8:\"\u0000*\u0000eissn\";s:0:\"\";s:9:\"\u0000*\u0000aulast\";s:7:\"DAPONTE\";s:10:\"\u0000*\u0000aufirst\";s:7:\"Antonio\";s:9:\"\u0000*\u0000auinit\";s:0:\"\";s:10:\"\u0000*\u0000auinitm\";s:0:\"\";s:5:\"\u0000*\u0000au\";a:9:{i:0;s:17:\"ASCIERTO, Paolo A\";i:1;s:16:\"GRAVINA, Adriano\";i:2;s:21:\"MELUCCI, Maria Teresa\";i:3;s:18:\"PALMIERI, Giuseppe\";i:4;s:17:\"COMELLA, Pasquale\";i:5;s:19:\"CELLERINO, Riccardo\";i:6;s:13:\"DELENA, Mario\";i:7;s:16:\"MARINI, Giovanni\";i:8;s:17:\"COMELLA, Giuseppe\";}s:9:\"\u0000*\u0000aucorp\";s:0:\"\";s:7:\"\u0000*\u0000isbn\";s:0:\"\";s:8:\"\u0000*\u0000coden\";s:6:\"CANCAR\";s:8:\"\u0000*\u0000genre\";s:7:\"article\";s:7:\"\u0000*\u0000part\";s:0:\"\";s:9:\"\u0000*\u0000btitle\";s:0:\"\";s:8:\"\u0000*\u0000title\";s:181:\"Cisplatin, dacarbazine, and fotemustine plus interferon a in patients with advanced malignant melanoma: A multicenter Phase II study of the Southern Italy Cooperative Oncology Group\";s:8:\"\u0000*\u0000place\";s:12:\"New York, NY\";s:6:\"\u0000*\u0000pub\";s:10:\"Wiley-Liss\";s:10:\"\u0000*\u0000edition\";s:0:\"\";s:9:\"\u0000*\u0000tpages\";s:0:\"\";s:9:\"\u0000*\u0000series\";s:0:\"\";s:8:\"\u0000*\u0000proxy\";s:30:\"http:\/\/proxyout.inist.fr:8080\/\";s:12:\"\u0000*\u0000integrite\";b:1;}"
arXiv access
